Cancer in systemic lupus: what drives the risk?
Bernatsky
Sasha
S
Clarke
A E
AE
Ramsey-Goldman
R
R
D016022:Case-Control Studies; D015331:Cohort Studies; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016014:Linear Models; D008180:Lupus Erythematosus, Systemic / Q000150:complications* / Q000188:drug therapy / Q000473:pathology*; D008297:Male; D015337:Multicenter Studies as Topic; D009369:Neoplasms / Q000150:complications*; D012307:Risk Factors; D012720:Severity of Illness Index; D012907:Smoking / Q000009:adverse effects
D007166:Immunosuppressive Agents; D003520:Cyclophosphamide